Whitson Bryan A, Prekker Matthew E, Herrington Cynthia S, Whelan Timothy P M, Radosevich David M, Hertz Marshall I, Dahlberg Peter S
Department of Surgery, Division of Cardiovascular and Thoracic Surgery, University of Minnesota, Minneapolis, Minnesota 55455, USA.
J Heart Lung Transplant. 2007 Oct;26(10):1004-11. doi: 10.1016/j.healun.2007.07.018.
Severe primary graft dysfunction (PGD) is associated with poor early outcomes after lung transplantation (LTx). Less is known about lingering effects of severe PGD on pulmonary function. The study's aim was to determine whether development of severe primary graft dysfunction in the perioperative period was associated with reduced long term rates of survival or with diminished long term pulmonary function.
A retrospective review was performed on LTx recipients who received their transplant during the period from 1992 through 2005. PGD severity over the first 48 hours post-transplant was graded using International Society for Heart Lung Transplantation criteria. Pulmonary function was evaluated yearly, and bronchiolitis obliterans syndrome (BOS) was determined from measurements of forced expiratory volume in 1 second (FEV(1)).
A total of 374 patients survived at least 90 days post-transplant. Overall survival rates were worse in patients with Grade 3 PGD: 51% at 5 years and 11% at 10 years for patients with Grade 3 PGD; 64% at 5 years and 35% at 10 years for those with Grade 2 PGD; and 66% at 5 years and 38% at 10 years for Grade 0 to 1 PGD (p = 0.001). BOS-free survival rate for patients with Grade 3 PGD was lower compared to those with Grade 0 to 2 for bilateral lung recipients, but not for single-lung recipients. Bilateral lung recipients who developed Grade 3 PGD had a significantly worse mean FEV(1) than those who did not. For single-lung recipients, PGD grade did not correlate with post-transplant pulmonary function.
Development of Grade 3 PGD in the early post-operative period negatively affects long-term survival, BOS-free survival and pulmonary function of bilateral lung transplant recipients who survive the peri-operative period.
严重原发性移植肺功能障碍(PGD)与肺移植(LTx)术后早期不良预后相关。关于严重PGD对肺功能的长期影响知之甚少。本研究的目的是确定围手术期严重原发性移植肺功能障碍的发生是否与长期生存率降低或长期肺功能减退有关。
对1992年至2005年期间接受移植的LTx受者进行回顾性研究。根据国际心肺移植学会标准对移植后最初48小时内的PGD严重程度进行分级。每年评估肺功能,并根据1秒用力呼气量(FEV(1))测量结果确定闭塞性细支气管炎综合征(BOS)。
共有374例患者移植后存活至少90天。3级PGD患者的总体生存率较差:3级PGD患者5年生存率为51%,10年生存率为11%;2级PGD患者5年生存率为64%,10年生存率为35%;0至1级PGD患者5年生存率为66%,10年生存率为38%(p = 0.001)。双侧肺移植受者中,3级PGD患者的无BOS生存率低于0至2级患者,但单肺移植受者并非如此。发生3级PGD的双侧肺移植受者的平均FEV(1)明显低于未发生者。对于单肺移植受者,PGD分级与移植后肺功能无关。
术后早期发生3级PGD对围手术期存活的双侧肺移植受者的长期生存、无BOS生存和肺功能产生负面影响。